ProShares Ultra NASDAQ Biotechnology
30 hedge funds and large institutions have $18.6M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
7
Closed
2
Calls
$7.58M
Puts
$6.62M
Net Calls
+$965K
Net Calls Change
+$3.71M